International Pilot Study for Dual Non-invasive Assesment of Embryo Development

Recruiting Observational Study
Infertility
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 42
Sex
Female
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Igenomix · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Choosing the best embryo is one of the major challenges for achieving success in in vitro fertilization (IVF). Traditionally, embryo evaluation has been based on morphological quality (how the embryo looks like) and chromosomal status as diagnosed by a genetic testing. However, recently new techniques that do not require manipulation of the embryo have been developed and have shown promising resul…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Study ICF signature. * Female age between 20 and 42 years (bot included). * IVF, ICSI or IVF/ICSI performed in fresh own or donated oocytes. Note: donor sperm is allowed. * niPGT-A cases with a deferred SET (of a day 6/7 vitrified blastocyst) for any medical indication. * Embr…
Contacts

Carlos Gomez, BSc MSc

+34963905310

carlos.gomez@igenomix.com

CONTACT

Ianae Ceschin, MSc

embrace@igenomix.com

CONTACT